Regulatory T cells in cardiovascular diseases (Q38622693)

4 September 2017

Regulatory T cells in cardiovascular diseases (English)

1 reference

4 September 2017

cardiovascular disease

1 reference

Xiao Meng

1

1 reference

4 September 2017

Jianmin Yang

2

1 reference

4 September 2017

Mei Dong

3

1 reference

4 September 2017

Kai Zhang

4

1 reference

4 September 2017

Eric Tu

5

1 reference

4 September 2017

Qi Gao

6

1 reference

4 September 2017

Wanjun Chen

7

1 reference

4 September 2017

Cheng Zhang

8

1 reference

4 September 2017

Yun Zhang

9

1 reference

4 September 2017

language of work or name

English

0 references

publication date

3 November 2015

1 reference

Nature Reviews Cardiology

4 September 2017

1 reference

4 September 2017

13

1 reference

4 September 2017

3

1 reference

4 September 2017

167-179

1 reference

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

4 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Immune effector mechanisms implicated in atherosclerosis: from mice to humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Protective Role of Interleukin-10 in Atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

IL-35-mediated induction of a potent regulatory T cell population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cutting edge: human CD4+CD25+ T cells restrain the maturation and antigen-presenting function of dendritic cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CTLA-4-Ig regulates tryptophan catabolism in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Modulation of tryptophan catabolism by regulatory T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Identification and monitoring of effector and regulatory T cells during experimental arthritis based on differential expression of CD25 and CD134.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Perforin: more than just a pore-forming protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

B cells and professional APCs recruit regulatory T cells via CCL4

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Translating molecular discoveries into new therapies for atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Control of inflammation by integration of environmental cues by regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells use "Itch" to control asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Effect of hyperlipidemia on Foxp3 expression in apolipoprotein E-knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Natural regulatory T cells control the development of atherosclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells ameliorate hyperhomocysteinaemia-accelerated atherosclerosis in apoE-/- mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Statins induce the accumulation of regulatory T cells in atherosclerotic plaque

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Expression of markers of regulatory CD4+CD25+foxp3+ cells in atherosclerotic plaques of human coronary arteries.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Decreased regulatory T cells in vulnerable atherosclerotic lesions: imbalance between pro- and anti-inflammatory cells in atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The Th17/Treg imbalance in patients with acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory/effector T-cell ratio is reduced in coronary artery disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Circulating CD4+CD25hiCD127lo regulatory T-Cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Progress and challenges in translating the biology of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The role of CD4+CD25+ regulatory T cells in macrophage-derived foam-cell formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Novel anti-inflammatory interleukin-35 as an emerging target for antiatherosclerotic therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

B cell depletion reduces the development of atherosclerosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Targeting B cells in atherosclerosis: closing the gap from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Immune regulation and vascular inflammation in genetic hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+Foxp3 regulatory T cells and vascular dysfunction in hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4+CD25+Foxp3+ regulatory T cells protect endothelial function impaired by oxidized low density lipoprotein via the KLF-2 transcription factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

T regulatory lymphocytes prevent aldosterone-induced vascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells ameliorate angiotensin II-induced cardiac damage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD4⁺CD25⁺Foxp3⁺ regulatory T cells suppress cardiac fibrosis in the hypertensive heart.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Role of T regulatory lymphocytes in the pathogenesis of high-fructose diet-induced metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Foxp3+ regulatory T cells play a protective role in angiotensin II-induced aortic aneurysm formation in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Abdominal aortic aneurysm: pathogenesis and implications for management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Deficient CD4+CD25+ T regulatory cell function in patients with abdominal aortic aneurysms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells limit vascular endothelial injury and prevent pulmonary hypertension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Athymic nude rats develop severe pulmonary hypertension following monocrotaline administration.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells and pulmonary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Understanding the Role of CD4+CD25 high (So-Called Regulatory) T Cells in Idiopathic Pulmonary Arterial Hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Important role of CCR2 in a murine model of coronary vasculitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

31 March 2020

Kawasaki Disease update

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cell microRNA expression changes in children with acute Kawasaki disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CD25+CD4+ regulatory T cells in patients with Kawasaki disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Experimental myocardial infarction induces altered regulatory T cell hemostasis, and adoptive transfer attenuates subsequent remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Low Levels of Circulating CD4+FoxP3+ T Cells Are Associated With an Increased Risk for Development of Myocardial Infarction But Not for Stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells ameliorate cardiac remodeling after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Activated regulatory T-cells attenuate myocardial ischaemia/reperfusion injury through a CD39-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells modulate postischemic neovascularization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells influence blood flow recovery in experimental hindlimb ischaemia in an IL-10-dependent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

A limited role for regulatory T cells in post-ischemic neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Presentation, patterns of myocardial damage, and clinical course of viral myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Pathogenesis of myocarditis and dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Autoimmune myocarditis: cellular mediators of cardiac dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells in virus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Upregulation of CD4+CD25+ T lymphocyte by adenovirus-mediated gene transfer of CTLA4Ig fusion protein in experimental autoimmune myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Susceptibility to autoimmune myocarditis is associated with intrinsic differences in CD4(+) T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Coxsackievirus B3 induces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Control of autoimmune myocarditis and multiorgan inflammation by glucocorticoid-induced TNF receptor family-related protein(high), Foxp3-expressing CD25+ and CD25- regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Endothelin receptor antagonist exacerbates autoimmune myocarditis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The role of Th17 cells and regulatory T cells in Coxsackievirus B3-induced myocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Decrease in dendritic cells in endomyocardial biopsies of human dilated cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Adoptive transfer of regulatory T cells protects against Coxsackievirus B3-induced cardiac fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Defective circulating CD4CD25+Foxp3+CD127(low) regulatory T-cells in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Prognostic value of circulating regulatory T cells for worsening heart failure in heart failure patients with reduced ejection fraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Leukocyte recruitment and ischemic brain injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Frequency and function of regulatory T cells after ischaemic stroke in humans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Immune activation in the peripheral blood of patients with acute ischemic stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Adoptive regulatory T-cell therapy protects against cerebral ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2015.169

Circulating CD4+CD25+ T cells in rheumatic mitral stenosis

31 March 2020

1 reference

12 December 2020

Imbalance between IL-17A-producing cells and regulatory T cells during ischemic stroke.

1 reference

12 December 2020

Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease

1 reference

12 December 2020

CD4⁺Foxp3⁺ Treg and its ICOS⁺ subsets in patients with myocardial infarction

1 reference

12 December 2020

Regulatory T cells and Atherosclerosis

1 reference

12 December 2020

Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction

1 reference

12 December 2020

Regulatory T-cell deficiency in rheumatic heart disease: a preliminary observational study

1 reference

12 December 2020

10.1038/NRCARDIO.2015.169

Identifiers

DOI

1 reference

4 September 2017

1 reference